P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL

• Jan Burger,
• Ekaterina Kim,
• Mariela Sivina,
• Ghayas Issa,
• Philip Thompson,
• William G. Wierda,
• Alessandra Ferrajoli

Affiliations

Jan Burger

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Ekaterina Kim

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Mariela Sivina

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Ghayas Issa

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Philip Thompson

2 Peter MacCallum Cancer Centre, Melbourne, Australia

William G. Wierda

1 The University of Texas MD Anderson Cancer Center, Houston, United States

Alessandra Ferrajoli

1 The University of Texas MD Anderson Cancer Center, Houston, United States